The use of chelating agents in the treatment of acute and chronic lead intoxication in childhood.
D000208:Acute Disease; D000596:Amino Acids / Q000097:blood / Q000652:urine; D000818:Animals; D001927:Brain Diseases / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D003404:Creatinine / Q000652:urine; D004112:Dimercaprol / Q000627:therapeutic use*; D004357:Drug Synergism; D004492:Edetic Acid / Q000627:therapeutic use*; D005198:Fanconi Syndrome / Q000150:complications; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007854:Lead / Q000097:blood / Q000652:urine; D007855:Lead Poisoning / Q000188:drug therapy*; D007982:Levulinic Acids / Q000097:blood / Q000652:urine; D010396:Penicillamine / Q000627:therapeutic use*; D010758:Phosphorus / Q000652:urine; D011817:Rabbits
D000596:Amino Acids; D007982:Levulinic Acids; D004112:Dimercaprol; D010758:Phosphorus; D007854:Lead; D004492:Edetic Acid; D003404:Creatinine; D010396:Penicillamine